Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis.
Cohen VML, O'Day RF.
Ophthalmol Ther. 2019 Dec;8(4):501-510. doi: 10.1007/s40123-019-00219-8. Epub 2019 Nov 6.
Primary acquired melanosis/melanoma: utility of conjunctival map biopsy.
Soto H, Bowen RC, Raval V, Yeaney G, Singh A.
Br J Ophthalmol. 2022 May;106(5):605-609. doi: 10.1136/bjophthalmol-2020-317772. Epub 2020 Dec 18.
Management of Primary Acquired Melanosis, Nevus, and Conjunctival Melanoma.
Kao A, Afshar A, Bloomer M, Damato B.
Cancer Control. 2016 Apr;23(2):117-25. doi: 10.1177/107327481602300205.
Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
Cid-Bertomeu P, Huerva V.
Surv Ophthalmol. 2022 Sep-Oct;67(5):1391-1404. doi: 10.1016/j.survophthal.2022.03.003. Epub 2022 Mar 9.
Recurrence of Primary Acquired Melanosis and Conjunctival Intraepithelial Neoplasia.
Svedberg K.
Ocul Oncol Pathol. 2023 Feb;8(4-6):236-241. doi: 10.1159/000526985. Epub 2022 Sep 14.
Tumors of the conjunctiva and cornea.
Shields CL, Shields JA.
Indian J Ophthalmol. 2019 Dec;67(12):1930-1948. doi: 10.4103/ijo.IJO_2040_19.
Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
Colby KA, Nagel DS.
Cornea. 2005 Apr;24(3):352-5. doi: 10.1097/01.ico.0000141229.18472.a2.
Spontaneous Regression of Unilateral Conjunctival Primary Acquired Melanosis.
Lando L, Krema H.
Ophthalmology. 2021 Sep;128(9):1324. doi: 10.1016/j.ophtha.2021.03.001.
PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
LeBlanc RE, Miller DM, Zegans ME.
J Cutan Pathol. 2021 Dec;48(12):1442-1448. doi: 10.1111/cup.14078. Epub 2021 Jun 18.
BRAF Mutation Status in Inflamed Juvenile Conjunctival Nevus, Primary Acquired Melanosis and Conjunctival Common Nevus.
Wang LC, Yu WK, Hsu CC, Huang YY, Tsai CC, Lin TC.
Clin Exp Ophthalmol. 2025 Sep 19. doi: 10.1111/ceo.14599. Online ahead of print.
